As chemical entities, lipoamino acids have been known for some time. However, more recently their occurrence and importance in mammalian species has been discovered. They appear to have close relationships with the endocannabinoids not only structurally but also in terms of biological actions. The latter include analgesia, anti-inflammatory effects, inhibition of cell proliferation and calcium ion mobilization. To date about 40 naturally occurring members of this family have been identified and, additionally, several synthetic analogs have been prepared and studied. To facilitate their identity, a nomenclature system has been suggested based on the name elmiric acid (EMA). The prototypic example, N-arachidonoyl glycine does not bind to CBI, however it does inhibit the glycine transporter GLYT2a and also appears to be a ligand for the orphan G-protein-coupled receptor GPRI8. It may also have a role in regulating tissue levels of anandamide by virtue of its inhibitory effect on FAAH the enzyme that mediates inactivation of anandamide. Its concentration in rat brain is several times higher than anandamide supporting its possible role as a physiological mediator. Future studies should be aimed at elucidating the actions of all of the members of this interesting family of molecules and gaining further insight into possible mechanisms of action. A promising use for these compounds would be as narcotic replacement agents.

Public Health Relevance

There can be little doubt that there is an important unmet need for safe and effective non narcotic drugs to treat chronic pain/inflammatory conditions such as rheumatoid arthritis. As our population continues to attain greater longevity, this problem will likely be on the increase. While a number of agents are currently in use, they are either very expensive or have significant adverse effects such as the development of dependence. In many instances of intractable pain, patients are forced to turn to narcotic type analgesics for relief. The studies proposed in this request for support are aimed at discovering safe and relatively inexpensive drug candidates to treat this problem as well as a host of other types of inflammation and resulting pain. If successful, one important benefit would be a reduction in the use of addiction producing medications.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA023635-01A2
Application #
7727687
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Hillery, Paul
Project Start
2009-08-01
Project End
2011-07-31
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
1
Fiscal Year
2009
Total Cost
$339,814
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Biochemistry
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Burstein, Sumner; McQuain, Catherine; Salmonsen, Rebecca et al. (2012) N-Amino acid linoleoyl conjugates: anti-inflammatory activities. Bioorg Med Chem Lett 22:872-5
Burstein, Sumner H; McQuain, Catherine A; Ross, Alonzo H et al. (2011) Resolution of inflammation by N-arachidonoylglycine. J Cell Biochem 112:3227-33